Can a 5-Session writing therapy ease PTSD in new moms?

NCT ID NCT07759882

First seen Aug 12, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This study explores whether a short, evidence-based therapy called Written Exposure Therapy (WET) can help pregnant and postpartum women who have PTSD and a history of substance misuse. Participants receive five weekly telehealth sessions where they write about a traumatic experience in a structured way to reduce emotional distress. The study focuses on whether this therapy is acceptable and feasible for this group, and also tracks changes in PTSD and depression symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Written Exposure Therapy (WET), a brief, evidence-based therapy where participants write about a traumatic experience in structured sessions to reduce PTSD symptoms.
What this could lead to
If this works, it could offer a practical, short-term therapy option for pregnant and postpartum women with PTSD who are also dealing with substance use, potentially improving mental health and recovery outcomes.
What could go wrong
This is a small feasibility study, not a large effectiveness trial, so results may not generalize. The therapy may not be acceptable to all participants, and it focuses on PTSD symptoms, not substance use directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WRITTEN EXPOSURE THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, 72205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.